Northern Trust’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-149,035
Closed -$340K 4465
2024
Q2
$340K Buy
149,035
+23,522
+19% +$53.6K ﹤0.01% 3651
2024
Q1
$542K Sell
125,513
-11
-0% -$48 ﹤0.01% 3537
2023
Q4
$383K Buy
125,524
+26,180
+26% +$79.8K ﹤0.01% 3634
2023
Q3
$143K Sell
99,344
-369
-0.4% -$531 ﹤0.01% 3921
2023
Q2
$248K Sell
99,713
-24,836
-20% -$61.8K ﹤0.01% 3741
2023
Q1
$334K Buy
124,549
+6,792
+6% +$18.2K ﹤0.01% 3617
2022
Q4
$639K Buy
117,757
+24,782
+27% +$135K ﹤0.01% 3417
2022
Q3
$1.16M Buy
92,975
+1,084
+1% +$13.5K ﹤0.01% 3265
2022
Q2
$454K Sell
91,891
-298,695
-76% -$1.48M ﹤0.01% 3569
2022
Q1
$2.97M Sell
390,586
-16,381
-4% -$124K ﹤0.01% 2887
2021
Q4
$4.16M Buy
406,967
+1,056
+0.3% +$10.8K ﹤0.01% 2804
2021
Q3
$5.45M Sell
405,911
-14,461
-3% -$194K ﹤0.01% 2675
2021
Q2
$9.22M Buy
420,372
+44,685
+12% +$980K ﹤0.01% 2429
2021
Q1
$9.04M Sell
375,687
-24,326
-6% -$585K ﹤0.01% 2359
2020
Q4
$7.2M Sell
400,013
-15,930
-4% -$287K ﹤0.01% 2457
2020
Q3
$4.8M Sell
415,943
-15,862
-4% -$183K ﹤0.01% 2554
2020
Q2
$10.5M Buy
431,805
+13,311
+3% +$323K ﹤0.01% 2061
2020
Q1
$4.61M Sell
418,494
-1,369
-0.3% -$15.1K ﹤0.01% 2350
2019
Q4
$11.1M Buy
419,863
+15,853
+4% +$419K ﹤0.01% 2109
2019
Q3
$9.2M Buy
404,010
+101,558
+34% +$2.31M ﹤0.01% 2197
2019
Q2
$9.27M Buy
302,452
+12,300
+4% +$377K ﹤0.01% 2198
2019
Q1
$4.82M Buy
290,152
+8,472
+3% +$141K ﹤0.01% 2586
2018
Q4
$5.39M Buy
281,680
+19,360
+7% +$371K ﹤0.01% 2460
2018
Q3
$13.7M Buy
262,320
+19,825
+8% +$1.04M ﹤0.01% 2061
2018
Q2
$10.5M Buy
242,495
+86,058
+55% +$3.74M ﹤0.01% 2234
2018
Q1
$5.8M Buy
156,437
+73,149
+88% +$2.71M ﹤0.01% 2502
2017
Q4
$1.65M Buy
83,288
+18,239
+28% +$362K ﹤0.01% 3231
2017
Q3
$1.62M Buy
+65,049
New +$1.62M ﹤0.01% 3293